GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » Treasury Stock

Origin Therapeutics Holdings (XCNQ:ORIG) Treasury Stock : C$0.00 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Origin Therapeutics Holdings's treasury stock for the quarter that ended in Jun. 2023 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Origin Therapeutics Holdings Treasury Stock Historical Data

The historical data trend for Origin Therapeutics Holdings's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Treasury Stock Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
Treasury Stock
- -

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Treasury Stock Get a 7-Day Free Trial Premium Member Only - - - - -

Origin Therapeutics Holdings Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines